Targeting HER2, BRAF, KRAS, MET

The 20th Annual Perspectives in Thoracic Oncology, held in New York, NY from November 21-22, 2015 provided thoracic oncology clinicians and researchers with the latest information on the complex biology and treatment of lung cancer. This conference series has become the premier forum to update knowledge in the field, confirm current best-practices, and provide valuable take-home information on exciting new screening and staging modalities, management approaches, and emerging treatment options.

in this presentation, Dr. Paul K. Paik examines the targeting of HER2, BRAF, KRAS, and MET for the treatment of lung cancer.

A continuing education program is offered as a supplement to this webcast at the following location:

© 2015 Imedex, LLC.